141 related articles for article (PubMed ID: 22199295)
21. Association of p53 polymorphisms with breast cancer: a case-control study in Slovak population.
Franeková M; Zúbor P; Stanclová A; Dussan CA; Bohusová T; Galo S; Dobrota D; Kajo K; Péc M; Racay P
Neoplasma; 2007; 54(2):155-61. PubMed ID: 17319790
[TBL] [Abstract][Full Text] [Related]
22. The p53 codon 72 polymorphism and lung cancer risk.
Fan R; Wu MT; Miller D; Wain JC; Kelsey KT; Wiencke JK; Christiani DC
Cancer Epidemiol Biomarkers Prev; 2000 Oct; 9(10):1037-42. PubMed ID: 11045785
[TBL] [Abstract][Full Text] [Related]
23. p53 codon 72 Pro homozygosity increases the risk of cutaneous melanoma in individuals with dark skin complexion and among noncarriers of melanocortin 1 receptor red hair variants.
Stefanaki I; Stratigos AJ; Dimisianos G; Nikolaou V; Papadopoulos O; Polydorou D; Gogas H; Tsoutsos D; Panagiotou P; Kanavakis E; Antoniou C; Katsambas AD
Br J Dermatol; 2007 Feb; 156(2):357-62. PubMed ID: 17223878
[TBL] [Abstract][Full Text] [Related]
24. COX2 and p53 risk-alleles coexist in COPD.
Arif E; Vibhuti A; Deepak D; Singh B; Siddiqui MS; Pasha MA
Clin Chim Acta; 2008 Nov; 397(1-2):48-50. PubMed ID: 18692035
[TBL] [Abstract][Full Text] [Related]
25. TP53 gene polymorphisms at codons 11, 72, and 248 and association with endometriosis in a Brazilian population.
Camargo-Kosugi CM; D'Amora P; Kleine JP; Carvalho CV; Sato H; Schor E; Silva ID
Genet Mol Res; 2014 Aug; 13(3):6503-11. PubMed ID: 25177931
[TBL] [Abstract][Full Text] [Related]
26. Analysis of the codon 72 polymorphism of the TP53 gene in patients with endometriosis.
Lattuada D; Viganò P; Somigliana E; Abbiati A; Candiani M; Di Blasio AM
Mol Hum Reprod; 2004 Sep; 10(9):651-4. PubMed ID: 15273281
[TBL] [Abstract][Full Text] [Related]
27. The different apoptotic potential of the p53 codon 72 alleles increases with age and modulates in vivo ischaemia-induced cell death.
Bonafé M; Salvioli S; Barbi C; Trapassi C; Tocco F; Storci G; Invidia L; Vannini I; Rossi M; Marzi E; Mishto M; Capri M; Olivieri F; Antonicelli R; Memo M; Uberti D; Nacmias B; Sorbi S; Monti D; Franceschi C
Cell Death Differ; 2004 Sep; 11(9):962-73. PubMed ID: 15131588
[TBL] [Abstract][Full Text] [Related]
28. Association between TP53 codon 72 single-nucleotide polymorphism and radiation sensitivity of human fibroblasts.
Alsbeih G; Al-Harbi N; Al-Buhairi M; Al-Hadyan K; Al-Hamed M
Radiat Res; 2007 May; 167(5):535-40. PubMed ID: 17474797
[TBL] [Abstract][Full Text] [Related]
29. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers.
Ji X; Neumann AS; Sturgis EM; Adler-Storthz K; Dahlstrom KR; Schiller JT; Wei Q; Li G
Carcinogenesis; 2008 Apr; 29(4):875-9. PubMed ID: 18258602
[TBL] [Abstract][Full Text] [Related]
30. Significant association of XPD codon 312 single nucleotide polymorphism with bladder cancer susceptibility in Taiwan.
Chang CH; Wang RF; Tsai RY; Wu HC; Wang CH; Tsai CW; Chang CL; Tsou YA; Liu CS; Bau DT
Anticancer Res; 2009 Oct; 29(10):3903-7. PubMed ID: 19846926
[TBL] [Abstract][Full Text] [Related]
31. p53 gene mutations and codon 72 polymorphism in ovarian carcinoma patients from Serbia.
Malisic E; Jankovic R; Slavkovic D; Milovic-Kovacevic M; Radulovic S
J BUON; 2010; 15(1):101-6. PubMed ID: 20414935
[TBL] [Abstract][Full Text] [Related]
32. Polymorphism of p53 gene codon 72 in Kuwaiti with coronary artery disease and diabetes.
Alkhalaf M; Al-Bustan S; Hamoda H; Abdella N
Int J Cardiol; 2007 Jan; 115(1):1-6. PubMed ID: 16797751
[TBL] [Abstract][Full Text] [Related]
33. p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.
Xu Y; Yao L; Ouyang T; Li J; Wang T; Fan Z; Lin B; Lu Y; Xie Y
Clin Cancer Res; 2005 Oct; 11(20):7328-33. PubMed ID: 16243804
[TBL] [Abstract][Full Text] [Related]
34. TP53 codon 72 polymorphism contributes to nasopharyngeal cancer susceptibility: a meta-analysis.
Zhuo XL; Cai L; Xiang ZL; Zhuo WL; Wang Y; Zhang XY
Arch Med Res; 2009 May; 40(4):299-305. PubMed ID: 19608020
[TBL] [Abstract][Full Text] [Related]
35. Proline homozygosity in codon 72 of p53 is a factor of susceptibility for thyroid cancer.
Granja F; Morari J; Morari EC; Correa LA; Assumpção LV; Ward LS
Cancer Lett; 2004 Jul; 210(2):151-7. PubMed ID: 15183530
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of p53 and X-ray repair cross-complementing group 1 polymorphisms on prostate-specific antigen recurrence in prostate cancer post radical prostatectomy.
Huang SP; Huang CY; Wang JS; Liu CC; Pu YS; Yu HJ; Yu CC; Wu TT; Huang CH; Wu WJ; Chou YH; Wu MT
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6632-8. PubMed ID: 18006764
[TBL] [Abstract][Full Text] [Related]
37. Differential association of the codon 72 p53 and GSTM1 polymorphisms on histological subtype of non-small cell lung carcinoma.
Liu G; Miller DP; Zhou W; Thurston SW; Fan R; Xu LL; Lynch TJ; Wain JC; Su L; Christiani DC
Cancer Res; 2001 Dec; 61(24):8718-22. PubMed ID: 11751390
[TBL] [Abstract][Full Text] [Related]
38. Polymorphism of the p53 tumor suppressor gene is associated with susceptibility to uterine leiomyoma.
Denschlag D; Bettendorf H; Watermann D; Keck C; Tempfer C; Pietrowski D
Fertil Steril; 2005 Jul; 84(1):162-6. PubMed ID: 16009172
[TBL] [Abstract][Full Text] [Related]
39. A novel single nucleotide polymorphism in ERCC6 gene is associated with oral cancer susceptibility in Taiwanese patients.
Chiu CF; Tsai MH; Tseng HC; Wang CL; Tsai FJ; Lin CC; Bau DT
Oral Oncol; 2008 Jun; 44(6):582-6. PubMed ID: 17933579
[TBL] [Abstract][Full Text] [Related]
40. A meta-analysis of the association between p53 codon 72 polymorphism and susceptibility to endometriosis.
Song GG; Lee YH
Immunol Invest; 2014; 43(6):595-605. PubMed ID: 24999736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
